Therapeutic considerations for disease progression in multiple sclerosis: Evidence, experience, and future expectations
- Elliot M. Frohman*
- , Olaf Stüve
- , Eva Havrdova
- , John Corboy
- , Anat Achiron
- , Robert Zivadinov
- , Per Soelberg Sorensen
- , J. Theodore Phillips
- , Brian Weinshenker
- , Kathleen Hawker
- , Hans Peter Hartung
- , Lawrence Steinman
- , Scott Zamvil
- , Bruce A.C. Cree
- , Stephen Hauser
- , Howard Weiner
- , Michael K. Racke
- , Massimo Filippi
*Corresponding author for this work
- University of Texas at Dallas
- University of Texas Southwestern Medical Center
- Heinrich Heine University Düsseldorf
- Charles University
- University of Colorado Denver
- Sheba Medical Center at Tel Hashomer
- SUNY Buffalo
- University of Copenhagen
- Texas Neurology
- Mayo Clinic Rochester, MN
- Stanford University
- University of California at San Francisco
- Massachusetts General Hospital
- IRCCS San Raffaele Scientific Institute
Research output: Contribution to journal › Review article › peer-review
38
Scopus
citations